Net Results Improve for Year on Higher Services Revenues, Lower
Expenses POWAY, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Digirad
Corporation (NASDAQ:DRAD), a leading provider of medical diagnostic
imaging systems and services to physicians' offices, hospitals and
imaging centers, today reported narrower losses for the twelve
months ended December 31, 2007, on higher annual revenues and lower
operating expenses for the year. Consolidated revenues for the
quarter were $18.8 million, up nine percent from $17.2 million in
fourth-quarter 2006. Revenue from its mobile imaging services
division or DIS rose 16 percent to $13.4 million from $11.6 million
in fourth-quarter 2006. Product-related revenue was $5.4 million,
and included sales of 18 cameras, compared to $5.6 million in
fourth-quarter 2006, including sales of 17 cameras. Consolidated
revenues for full-year 2007 were $73.9 million, compared to $71.9
million in 2006. DIS revenue was $52.4 million, compared to $49.6
million for 2006. Product-related revenue was $21.5 million,
including sales of 73 cameras, compared to $22.3 million in 2006,
which included sales of 71 cameras. Chief Executive Officer Mark
Casner commented: "We are pleased with our achievements in 2007:
our acquisition of Ultrascan, the launch of our Centers of
Influence strategy, the improvement in our product margins, and the
reduction of our operating loss by $5.4 million compared to 2006."
Consolidated gross profit decreased by nine percent to $4.5 million
for the quarter, principally due to decreased DIS profitability
attributable to greater than normal seasonality and the disruption
in radioisotope supplies announced previously. Gross margin was 24
percent of revenues in the fourth quarter of 2007, compared to 28
percent of revenues in 2006. Consolidated gross profit for
full-year 2007 increased by eight percent to $20.5 million, or 28
percent of revenues, compared to $19.1 million, or 26 percent of
revenues in 2006. Net loss for the quarter was $1.1 million, or
$(0.06) per share, compared to a fourth-quarter 2006 net loss of
$149,000, or $(0.01) per share. The $1.0 million increase in net
loss for fourth-quarter 2007 was due in part to a decline in DIS
gross profit, increased amortization costs associated with the
intangible assets arising from the Ultrascan acquisition of
$185,000, and a fourth-quarter charge of $300,000 primarily from
impairment of certain long-term assets. Despite higher net losses
for the fourth quarter, net loss for the year declined more than 75
percent to $1.4 million, or $(0.07) per share, compared to a net
loss of $6.3 million, or $(0.34) per share, incurred in 2006. Total
operating expenses for full-year 2007 declined to $23.4 million, or
32 percent of revenues, from $27.3 million, or 38 percent of
revenues, in 2006. For the quarter, DIS operated 136 units, both
nuclear and ultrasound, with an overall asset utilization rate of
60 percent, compared to 83 units (all nuclear) and an asset
utilization rate of 56 percent for fourth-quarter 2006. During the
quarter the Company continued to upgrade its mobile imaging
services' nuclear camera fleet by replacing six single-head cameras
with its multi-headed Cardius XPO configuration. The Company's
fleet of mobile cameras now includes 61 multi-headed cameras. The
ongoing upgrades are expected to increase reliability and patient
throughput and thereby lead to higher utilization and lower labor
costs in subsequent periods. Cash and equivalents and securities
available for sale on December 31, 2007, totaled $31.7 million,
compared to $44.3 million on December 31, 2006. Cash usage for 2007
included $8.8 million in payments toward the acquisition of
Ultrascan net assets and $8.6 million for capital expenditures
primarily associated with the fleet upgrade of the Company's mobile
imaging services operations. Cash usage was offset in part by
positive cash flows from operations of $4.7 million during the
year. Net receivables were $8.5 million, compared to $7.5 million
on December 31, 2006. Net inventories were $5.5 million, compared
to $5.9 million on December 31, 2006. Focus for 2008 Casner further
commented: "Looking forward, our key focus for 2008 will be driving
DIS revenue growth through our Centers of Influence strategy,
increasing our mobile imaging fleet utilization which should
translate into a profitable 2008 for our DIS business, and reaching
profitability for the first time in the history of our product
business, as we intend to increase product-related revenue, reduce
costs and improve reliability in this business segment." Management
Reaffirms Guidance for 2008 For full-year 2008, the Company
anticipates consolidated revenues in a range of $80 million to $84
million, consisting of DIS imaging services revenue of $59 million
to $61 million and product-related revenue of $21 million to $23
million; and consolidated net results for 2008 to range from net
income of $500,000 to a net loss of $1 million, including estimated
stock-based compensation expense of $1 million. Conference Call
Information Digirad has scheduled a conference call at 11:00 a.m.
EDT today. A simultaneous webcast of the call may be accessed
online from the Events & Presentations link on the Investor
Relations page at http://www.digirad.com/; an archived replay of
the webcast will be available within 15 minutes of the end of the
conference call. A telephone replay of the call will be available
at (800) 406-7325 or (303) 590-3030, conference ID #3838461, from
approximately 2 p.m. EST. The telephone replay will be available
until 11:59 p.m. EST on February 9. About Digirad Digirad
Corporation provides diagnostic nuclear and ultrasound imaging
systems and services to physicians' offices, hospitals and other
medical services providers for cardiac, vascular, and general
imaging applications. Digirad's Cardius XPO line of nuclear imaging
cameras use patented solid-state technology and unique multi
(single, dual, triple) head design for superior performance and
advanced features for sharper digital images, faster processing,
compact size, lighter weight for portability, ability to handle
patients up to 500 pounds, and improved patient comfort compared to
standard nuclear cameras. Digirad's 2020tc general-purpose nuclear
imager has a small footprint and may also be configured for fixed
or mobile use to supplement primary imaging. Digirad's installed
base of nuclear equipment exceeds 500 systems; in addition, a
mobile fleet of more than 136 nuclear and ultrasound imaging
systems is being used in 23 states, primarily in the eastern,
midwestern and southwestern United States. For more information,
please visit http://www.digirad.com/. Digirad(R), Digirad Imaging
Solutions(R), and Cardius(R) are registered trademarks of Digirad
Corporation. Forward-Looking Statements Statements in this press
release that are not a description of historical facts are forward
looking statements. You can identify these statements by the fact
that they do not relate strictly to historical or current facts and
use words such as "anticipate," "estimate," "expect," "project,"
"intend," "plan," "believe" and other words and terms of similar
meaning. Examples of such forward looking statements include
statements regarding revenue growth, gross margin improvements,
declining operating expenses, performance and costs benefits from
the ongoing upgrade of the mobile imaging fleet, anticipated
revenue in 2008 from the Company's centers of influence strategy,
potential acquisitions, and, in general, anticipated financial
results for 2008. Actual performance and benefits results may
differ materially from those set forth in this press release due to
risks and uncertainties inherent in Digirad's business including,
without limitation, changes in business conditions, technology,
customers' business conditions, work force, suppliers, business
prospects, economic outlook, operational policy or structure,
acceptance and use of Digirad's camera systems and services,
reliability, recalls, and other risks detailed in Digirad's filings
with the U.S. Securities and Exchange Commission, including Annual
Report on Form 10-K, Quarterly Reports on Form 10-Q, Form 8-K and
other reports. Readers are cautioned to not place undue reliance on
these forward looking statements, which speak only as of the date
hereof. All forward looking statements are qualified in their
entirety by this cautionary statement, and Digirad undertakes no
obligation to revise or update the forward looking statements
contained herein. Digirad Corporation Condensed Consolidated
Statements of Operations (In thousands, except per share amounts)
Three Months Ended Twelve Months Ended December 31, December 31,
2007 2006 2007 2006 (unaudited) (unaudited) Revenues: DIS $13,420
$11,606 $52,440 $49,614 Product 5,403 5,641 21,507 22,312 Total
revenues 18,823 17,247 73,947 71,926 Cost of revenues: DIS 10,749
8,595 39,520 37,675 Product 3,582 3,742 13,909 15,192 Total cost of
revenues 14,331 12,337 53,429 52,867 Gross profit 4,492 4,910
20,518 19,059 Operating expenses: Research and development 631 645
3,072 3,894 Sales and marketing 2,009 2,030 7,670 8,827 General and
administrative 2,794 2,846 11,920 14,535 Amortization and
impairment of intangible assets 371 (8) 697 27 Total operating
expenses 5,805 5,513 23,359 27,283 Loss from operations (1,313)
(603) (2,841) (8,224) Interest income, net 343 454 1,566 1,988
Other expense (130) -- (101) (54) Net loss $(1,100) $(149) $(1,376)
$(6,290) Net loss per share - basic $(0.06) $(0.01) $(0.07) $(0.34)
and diluted Weighted average shares outstanding: Basic and diluted
18,916 18,791 18,845 18,761 Stock-based compensation expense is
included in the above as follows: Cost of DIS revenue $10 $17 $71
$141 Cost of Product revenue (11) 9 49 74 Research and development
15 -- 77 130 Sales and marketing 35 41 102 279 General and
administrative 32 110 606 942 Digirad Corporation Condensed
Consolidated Balance Sheets(1) (in thousands) December 31, 2007
2006 (unaudited) Assets Cash and cash equivalents $14,922 $10,070
Securities available-for-sale 16,740 34,256 Accounts receivable,
net 8,536 7,534 Inventories, net 5,455 5,860 Other current assets
1,786 1,499 Total current assets 47,439 59,219 Property and
equipment, net 16,235 9,570 Other intangible assets, net 2,631 428
Goodwill 2,650 -- Restricted cash 60 60 Total assets $69,015
$69,277 Liabilities and stockholders' equity Accounts payable
$2,650 $2,643 Accrued compensation 3,547 3,650 Accrued warranty 930
788 Other accrued liabilities 3,285 3,306 Deferred revenue 2,909
2,775 Current portion of long-term debt 213 269 Total current
liabilities 13,534 13,431 Long-term debt, net of current portion --
99 Deferred rent 234 302 Total stockholders' equity 55,247 55,445
Total liabilities and stockholders' equity $69,015 $69,277 (1) The
condensed consolidated balance sheet as of December 31, 2006, was
derived from the audited financial statements as of that date.
DATASOURCE: Digirad Corporation CONTACT: investor contact, Dan
Matsui of Allen & Caron, +1-949-474-4300, for Digirad
Corporation; or company contact, Todd Clyde, CFO of Digirad
Corporation, +1-858-726-1600, Web site: http://www.digirad.com/
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jul 2023 to Jul 2024